← FDA Drug Approvals (Drugs@FDA)

TIOPRONIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PH HEALTH · Approved 2023-02-24

Drug application

FDA Application #
ANDA217219
Application type
Abbreviated New Drug Application (Generic)
Brand name
TIOPRONIN
Generic name
TIOPRONIN
Active ingredients
TIOPRONIN
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Marketing status
Prescription
Sponsor
PH HEALTH
Manufacturer
Endo USA, Inc.
First approval
2023-02-24

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown